Marinus Pharmaceuticals, Inc. (MRNS) financial statements (2022 and earlier)

Company profile

Business Address 5 RADNOR CORPORATE CENTER SUITE 500
RADNOR, PA 19087
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments122,927139,98391,68272,72553,39230,10056,196
Cash and cash equivalents122,927138,50990,94367,72733,53126,17851,722
Short-term investments 1,4747394,99819,8613,9224,474
Receivables2,629      
Contract with customer, asset 1,646  
Other undisclosed current assets6,1224,6382,4521,2159781991,571
Total current assets:131,678146,26794,13473,94054,37030,29957,767
Noncurrent Assets
Property, plant and equipment2,4991,9452,2651,2941,3381,14831
Long-term investments and receivables    4,964 1,488
Long-term investments    4,964 1,488
Other noncurrent assets2,6632,2502,443   376
Total noncurrent assets:5,1624,1954,7081,2946,3021,1481,895
TOTAL ASSETS:136,840150,46298,84275,23460,67231,44759,662
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities19,33310,7298,0316,9092,5444,5845,307
Accounts payable3,1262,2112,7632,4729272,8093,146
Accrued liabilities16,2078,5185,2684,4371,6171,7752,161
Debt     3,5002,128
Other undisclosed current liabilities21,233      
Total current liabilities:40,56610,7298,0316,9092,5448,0847,435
Noncurrent Liabilities
Long-term debt and lease obligation40,809    1,7435,250
Long-term debt, excluding current maturities40,809    1,7435,250
Liabilities, other than long-term debt1,9792,5343,042 12014156
Accounts payable and accrued liabilities1,9792,5343,042 12014156
Total noncurrent liabilities:42,7882,5343,042 1201,8845,306
Total liabilities:83,35413,26311,0736,9092,6649,96812,741
Temporary equity, carrying amount  28,200    
Stockholders' equity
Stockholders' equity attributable to parent53,486137,19959,56968,32558,00821,47946,921
Preferred stock4,3024,469     
Common stock37378753412019
Additional paid in capital459,852444,622295,056249,727202,790147,288144,088
Accumulated other comprehensive loss   (2)(96)  
Accumulated deficit(410,705)(311,929)(235,574)(181,453)(144,727)(125,829)(97,186)
Total stockholders' equity:53,486137,19959,56968,32558,00821,47946,921
TOTAL LIABILITIES AND EQUITY:136,840150,46298,84275,23460,67231,44759,662

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues15,345      
Cost of revenue
(Cost of Goods and Services Sold)
(1,478)      
Gross profit:13,867      
Operating expenses(110,798)(69,655)(54,422)(37,179)(19,043)(28,242)(24,432)
Other undisclosed operating income 1,718   77
Operating loss:(96,931)(67,937)(54,422)(37,179)(19,043)(28,242)(24,432)
Nonoperating income1,667459309532332  
Investment income, nonoperating80496362533352  
Foreign currency transaction gain, before tax930      
Other nonoperating income (expense)657(37)(53)(1)(20)  
Interest and debt expense(2,582)   (159)(464)(475)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes 3(8)(79)(28)  
Loss from continuing operations before equity method investments, income taxes:(97,846)(67,475)(54,121)(36,726)(18,898)(28,706)(24,907)
Other undisclosed loss from continuing operations before income taxes(930)      
Net loss:(98,776)(67,475)(54,121)(36,726)(18,898)(28,706)(24,907)
Other undisclosed net income attributable to parent     6357
Net loss attributable to parent:(98,776)(67,475)(54,121)(36,726)(18,898)(28,643)(24,850)
Preferred stock dividends and other adjustments (8,880)     
Net loss available to common stockholders, diluted:(98,776)(76,355)(54,121)(36,726)(18,898)(28,643)(24,850)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(98,776)(67,475)(54,121)(36,726)(18,898)(28,706)(24,907)
Comprehensive loss:(98,776)(67,475)(54,121)(36,726)(18,898)(28,706)(24,907)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   94(96)  
Comprehensive loss, net of tax, attributable to parent:(98,776)(67,475)(54,121)(36,632)(18,994)(28,706)(24,907)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: